Health & Wellness Oxford Biodynamics surges after Pfizer trial backs blood-based cancer test The platform makes it possible to track disease progression and therapy effectiveness in real-time Joseph MortonJuly 18, 2025
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph MortonMay 27, 2025
Medical and Pharmaceutical Breath Diagnostics now offering a compelling investment opportunity The lung cancer breath test developer is enabling investors to buy US$3 shares through a Reg CF financing Rowan DunneMay 7, 2025